Skin cells from people with Parkinson’s disease were transformed into stem cells that could generate dopamine-producing neurons, the same type that’s progressively lost with the disease. The technique opens new avenues for cell therapies to treat Parkinson’s while avoiding possible immune rejections. The researchers used animal models of the…
A sensor chip that can distinguish harmless single units of proteins tied to diseases like Parkinson’s from those whose toxic aggregates are thought to drive disease — including alpha-synuclein — could help in diagnosing conditions before symptoms are evident, when treatments can work best, a study suggests. In addition…
Among available dopamine agonists to treat early Parkinson’s disease, ropinirole is the least likely to cause dyskinesia, the  involuntary movements that can occur from long-term use of these and other Parkinson’s medications, a meta-analysis study suggests. Pramipexole, meanwhile, may be the least likely to cause wearing off…
Gaps in healthcare for individuals with Parkinson’s disease in the U.S. have been identified, with notable disparities observed for women, individuals belonging to minority groups, and residents living in rural areas. That’s according to a study utilizing 2019 Medicare data, which includes approximately 90% of individuals living with Parkinson’s…
The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s software called Vercise Neural Navigator 5, which provides visual guidance on how to best program deep brain stimulation (DBS) settings for Parkinson’s disease. The improved software features an enhanced user-friendly interface that presents simplified patient data and…
Imaging software developed by Braintale may distinguish Parkinson’s disease from atypical parkinsonism based on measures of early changes in the brain’s white matter, aiding in better diagnoses and disease treatment development. That’s according to initial results from a study into biomarkers on magnetic resonance…
Using a smartwatch to track how fast people can move may help identify who’s at risk for Parkinson’s disease up to seven years before symptoms become evident and doctors make a diagnosis, a study suggests. Wearing the smartwatch for a week was enough to feed an artificial intelligence (AI)-powered…
The Center for Movement Disorders and Neurorestoration at the University of California (UC) Davis Health Department of Neurology will serve as a Parkinson’s Foundation Center of Excellence starting this month and for at least the next five years. The center joins a Global Care Network that’s grown…
BrainTale raised €4.5 million (about $5 million) to speed further development of software that can decode changes in the brain’s white matter into information that can predict, diagnose, and monitor the progression of diseases such as Parkinson’s. With this round of financing, led by investors Capital Grand…
UB-312, an experimental vaccine by Vaxxinity, appeared safe and well tolerated and was able to produce an immune response against toxic alpha-synuclein protein aggregates in people with early Parkinson’s disease, according to data from a clinical trial. According to the company, UB-312 met the primary objectives of the…
Get regular updates to your inbox.